Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 28, 2018
Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017
VANCOUVER, March 28, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral ...
March 28, 2018
Heron Therapeutics Announces Proposed Public Offering of Common Stock
SAN DIEGO--(BUSINESS WIRE)--Heron Therapeutics, Inc. (HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of ...
March 28, 2018
Molecular Templates, Inc. Reports Fourth Quarter 2017 Financial Results
AUSTIN, Texas, March 28, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of the company’s ...
March 28, 2018
Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update
GAITHERSBURG, Md., March 28, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the year ended December 31, ...
March 27, 2018
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
SAN DIEGO, March 26, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced the completion of its previously announced underwritten public offering of 9,775,000 shares of its ...
March 27, 2018
Galmed Pharmaceuticals to Present New Scientific Data on the Mechanism by Which Aramchol Exerts its Effect on Fibrosis at EASL
TEL AVIV, Israel, March 27, 2018 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the ...
March 27, 2018
BioTime Announces Cash Sale of Ascendance Biotechnology
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that IVT Holdings acquired Ascendance Biotechnology, Inc. BioTime’s ...
March 27, 2018
Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that it has dosed the first subjects in a Phase 1/2 clinical study of ARO-HBV, which is ...
March 27, 2018
Tyme Announces First Site Open for its Phase II Trial with SM-88 in Pancreatic Cancer
NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME) (“Tyme” or the “Company”) announced today that the first site for the Phase II ...
March 27, 2018
Pernix Therapeutics Announces Return to Market of Zohydro® ER with BeadTek® 20 mg
MORRISTOWN, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, today announced that it expects to resume distribution ...
March 27, 2018
HTG Molecular Diagnostics Secures Debt Facility with MidCap Financial
TUCSON, Ariz., March 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications ...
March 27, 2018
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update on Its Phase 1b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection
GAITHERSBURG, Md., March 27, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced positive data from its Phase 2a study of ...
March 27, 2018
STRATA Skin Sciences, Inc. to Report Fiscal 2017 Financial Results on Thursday, March 29
HORSHAM, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to ...
March 27, 2018
Krystal Submits Investigational New Drug (IND) Application for KB103, Topical Gene Therapy Candidate for Dystrophic Epidermolysis Bullosa
PITTSBURGH, March 27, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing “off-the-shelf” treatments for rare dermatological diseases, announces the ...
March 27, 2018
Caelum Biosciences Announces Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis
NEW YORK, March 27, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (FBIO) Company developing treatments for rare and life-threatening diseases, ...
March 27, 2018
Oncobiologics Appoints Dr. Joerg Windisch to Board of Directors
CRANBURY, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today announced the appointment of Joerg Windisch, Ph.D. to its board of directors, effective ...
March 26, 2018
Prometic to report its Fourth Quarter and Year-End 2017 Financial Results and hold Conference Call / Webcast
LAVAL, QC, March 26, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic") announced today that it will report its financial results for the fourth ...
March 26, 2018
Heat Biologics Reports Positive Data to Further Support the Mechanism of Action for its Proprietary T-Cell Activation Platform
DURHAM, NC / ACCESSWIRE / March 26, 2018 / Heat Biologics, Inc. (HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system ...
March 26, 2018
Intec Pharma Appoints Roger J. Pomerantz, M.D. to Board of Directors
JERUSALEM, March 26, 2018 /PRNewswire/ -- Intec Pharma LTD (NASDAQ, TASE: NTEC) ("Intec" or "the Company") today announces the appointment of Roger J. Pomerantz, M.D., F.A.C.P. ...
March 26, 2018
Catalyst Biosciences Receives $1.5 Million In Two Milestone Payments for Neuronal Nicotinic Receptor (NNR) Asset
SOUTH SAN FRANCISCO, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
Page 64 of 127